Concerns & Risks -- 6/10
Zero China exposure (exited 2019) and low regulatory risk -- best-in-class geopolitical profile.
Multiple credible near-term catalysts (volume re-acceleration, Millersburg plant, Benepack, India,
$800M capital return). But forward EV/EBITDA ~10.6x sits above Crown Holdings ~8.6x -- a
premium-to-peer valuation that caps the score.
Weight: 15%
Fwd EV/EBITDA (FY26E)
~10.6x
vs Crown ~8.6x | Above peer
China Exposure
~0%
Exited 2019 | Best-in-class
Net Debt / EBITDA
3.33x
TTM | Targeting 2.7x by YE26 | Elevated
Capital Return (FY26)
$800M+
Incl. $600M+ buybacks | Shareholder-friendly
Valuation vs. peers
| Metric |
Ball (BALL) |
Crown (CCK) |
Assessment |
| EV/EBITDA (FY26E) |
~10.6x |
~8.6x |
~2-turn premium to closest peer |
| EBITDA (FY26E) |
~$2,200M |
-- |
|
Ball is the clear #1 global can maker, which justifies some premium. But on a like-for-like basis
the stock trades well above the peer average. The ~2-turn gap to Crown is the single largest drag
on this score.
Data sourced from
Daloopa.
China / geopolitical exposure
Zero. Ball exited China in 2019, selling its facilities to ORG Technology.
No Middle East business. Supply chains run "as short as possible" per management commentary.
Best-in-class geopolitical profile among global packaging names.
Near-term catalysts
| Catalyst |
Detail |
Timeline |
| Volume re-acceleration |
April volumes mid-single-digit growth; South America +20% in April. |
Q2 2026 |
| Millersburg plant |
Commissioning late 2026, full ramp 2027. Long-term offtake agreements in place. |
H2 2026 |
| Benepack acquisition |
Belgium + Hungary capacity. EMEA volumes running above 3-5% guide. |
Integrating |
| Capital return |
$800M+ in FY2026, including $600M+ in share buybacks. |
FY2026 |
| India capacity |
One plant expanded, second announced. High-teens growth market. |
2026-2027 |
| Deleveraging |
Year-end 2026 target ~2.7x net debt/EBITDA, down from 3.33x TTM. |
YE 2026 |
Regulatory risk
Low overhang. Section 232 aluminum tariffs have de minimis impact --
costs are passed through contractually. EPR and deposit-return schemes are a long-term structural
tailwind for aluminum cans vs. plastic alternatives. No material regulatory risk on the horizon.
Bull case
#1 global can maker with zero China/Middle East exposure. Fully-contracted book (>90% sold
for 2027). Accelerating Q2 volumes (mid-single-digit NA, +20% South America in April). Three
capacity catalysts (Millersburg, Benepack, India). Pass-through cost model insulates margins.
Deleveraging from 3.33x toward 2.7x by year-end 2026. $800M+ capital return including $600M+
buybacks.
Bear case
Forward EV/EBITDA ~10.6x is a ~2-turn premium to Crown Holdings. Net debt/EBITDA 3.33x TTM
remains elevated. Volume growth is low-single-digit and capacity-constrained until Millersburg
ramps in 2027. CEO and CFO are both new. $35M Millersburg start-up costs hit Q3 2026.
Score rationale
Score of 6/10 reflects a best-in-class geopolitical profile and multiple credible catalysts, offset by a premium valuation that leaves limited margin for error.
Why 6 and not higher: Forward EV/EBITDA ~10.6x sits ~2 turns above Crown Holdings (~8.6x). Net debt/EBITDA 3.33x TTM is elevated vs. the 2.7x year-end target. Volume growth is low-single-digit until Millersburg capacity comes online. Both CEO and CFO are new. The premium-to-peer valuation is the binding constraint.
Why 6 and not lower: Zero China/Middle East exposure is best-in-class. Pass-through cost model insulates margins from tariff risk. Six credible near-term catalysts (volume re-acceleration, Millersburg, Benepack, India, capital return, deleveraging). >90% of 2027 volumes already contracted. EPR regulation is a structural tailwind. Low regulatory overhang.